To read the full version of this content please select one of the options below:

Multi‐perspective analysis of the Chinese pharmaceutical sector: Policy, enterprise and technology

Leong Chan (Portland State University, Portland, Oregon, USA)
Tugrul U. Daim (Portland State University, Portland, Oregon, USA)

Journal of Technology Management in China

ISSN: 1746-8779

Article publication date: 31 May 2011

Abstract

Purpose

The purpose of this paper is to analyze the Chinese pharmaceutical sector through three levels: policy level, enterprise level, and technology level.

Design/methodology/approach

The authors explore the environmental impacts, which include political, social, and economic factors, study enterprise‐level strategies on international technology transfer and carry out a trend analysis on the technology development in the Chinese pharmaceutical industry.

Findings

The results indicate that China is emerging in the biopharmaceutical industry. While there are several steps to be taken at different levels, including policy, enterprise, and technology, the country is presenting a potential for the future. The paper outlines the gaps in each area.

Originality/value

The paper provides a very good outline against which any emerging economy could review its potential in the pharmaceutical industry.

Keywords

Citation

Chan, L. and Daim, T.U. (2011), "Multi‐perspective analysis of the Chinese pharmaceutical sector: Policy, enterprise and technology", Journal of Technology Management in China, Vol. 6 No. 2, pp. 171-190. https://doi.org/10.1108/17468771111142973

Publisher

:

Emerald Group Publishing Limited

Copyright © 2011, Emerald Group Publishing Limited